phrykt

Kewaunee Scientific Corp /De/ (KEQU): who owns it and who trades it

As of Nov 12, 2026, KEQU insiders reported 7 open-market sales worth $293K and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Thomas David Hull III (CEO), with $218K. 1 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 12, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Kewaunee Scientific

From the latest filings

Overall: more selling than buying. Insiders and famous investors mostly sold. Funds mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns KEQU

32 funds and institutions reported KEQU shares worth $42.6M at the end of Q2 2026, about 42% of the company. The largest holder is Northern Trust Corp with 8.3%.

Funds and institutions (13F) 42%Everyone else 58%

10 largest owners, by share of the company

Northern Trust Corp8.3%
Dimensional Fund Advisors LP6.1%
Minerva Advisors LLC5.2%
Vanguard Capital Management LLC3.8%
Punch & Associates Investment Management, Inc.3.7%
Renaissance Technologies LLC3.3%
De Lisle Partners LLP1.8%
Royce & Associates LP1.7%
American Century Companies Inc1.7%
Geode Capital Management, LLC0.9%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Northern Trust Corp238,1118.30%$8.5M-3%
Dimensional Fund Advisors LP175,0426.10%$6.2M-1%
Minerva Advisors LLC149,4105.21%$5.3M+9%
Vanguard Capital Management LLC110,0513.83%$3.9M-2%
Punch & Associates Investment Management, Inc.105,5453.68%$3.7M+5%
Renaissance Technologies LLC95,3113.32%$3.4M-3%
De Lisle Partners LLP52,6261.83%$1.9MNo change
Royce & Associates LP49,7001.73%$1.8M+4%
American Century Companies Inc49,5301.73%$1.8MNo change
Geode Capital Management, LLC24,9310.87%$886K+2%
Mink Brook Asset Management LLC21,4470.75%$762KNo change
Northeast Investment Management20,0000.70%$710KNo change
Morgan Stanley16,8280.59%$598K-16%
Vanguard Fiduciary Trust Co13,1720.46%$468K+1%
Wealth Enhancement Advisory Services, LLC12,6940.44%$465KNo change
BlackRock, Inc.11,9780.42%$425K+21%
Bridgeway Capital Management, LLC11,8150.41%$420KNo change
State Street Corp10,0340.35%$356KNo change
Verdad Advisers, LP10,0000.35%$355KNew
LPL Financial LLC8,0000.28%$284KNo change

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, KEQU insiders reported $0 of open-market purchases and $293K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$293K
7 trades, 2 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Jan 7, 2026
Filed Jan 8, 2026

Purchases and sales by month

$157K$157KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Jan 7, 2026Thomas David Hull IIICEOSale2,177$37.50$81.6KForm 4
Jan 6, 2026Donald T. Gardner IIICFOSale2,000$37.57$75.1KForm 4
Dec 31, 2025Thomas David Hull IIICEOSale629$37.66$23.7KForm 4
Dec 30, 2025Thomas David Hull IIICEOSale29$38.00$1.1KForm 4
Dec 29, 2025Thomas David Hull IIICEOSale884$38.01$33.6KForm 4
Dec 22, 2025Thomas David Hull IIICEOSale1,000$39.00$39KForm 4
Dec 17, 2025Thomas David Hull IIICEOSale1,000$39.00$39KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Thomas David Hull IIIPresident, CEO, Director–$218KJan 7, 2026
Donald T. Gardner IIIChief Financial Officer–$75.1KJan 6, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

KEQU short interest

Low short interest. 1.3% of KEQU shares are sold short: about 1 share in 76. Over the last 12 reports the number of shares short went down 10%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 38,286 KEQU shares were sold short, 1.3% of the shares outstanding, down 3.4% from the report before. At the average daily volume of 2,667 shares, buying them all back would take about 14.4 trading days (days to cover).

Shares short, % of all shares

1.32%May 15Oct 301.82%

Days to cover

14.4May 15Oct 3027.8

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 202638,2861.32%-3%2,66714.4
Oct 15, 202639,6271.37%-10%4,5478.7
Sep 30, 202643,9571.52%-10%5,4688.0
Sep 15, 202648,9091.69%+3%3,67313.3
Aug 31, 202647,5831.66%+7%1,91324.9
Aug 14, 202644,5641.55%-6%3,51012.7
Jul 31, 202647,5781.66%-2%5,7778.2
Jul 15, 202648,3231.68%-4%5,0539.6
Jun 30, 202650,3991.76%+15%9,2445.5
Jun 15, 202643,6671.52%+5%2,62516.6
May 29, 202641,5321.45%-2%2,59316.0
May 15, 202642,3901.48%-6%1,93022.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Kewaunee Scientific company events

Kewaunee Scientific filed 12 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Nov 2, 2026.

  1. Nov 2, 2026AgreementKewaunee Scientific Corporation entered into a Securities Purchase Agreement, dated as of the Signing Date, by and among the Company, NYCOM, Inc., and the seller parties set forth on the signature pages thereto, pursuant to which the Company agreed to acquire NYCOM, subject to the terms and… Filing
  2. Sep 9, 2026ResultsReleased financial results. Filing
  3. Aug 27, 2026VoteReported shareholder vote results. Filing
  4. Aug 26, 2026AnnouncementShared information with investors. Filing
  5. Aug 25, 2026AnnouncementKewaunee Scientific Corporation announced that the Company plans to release its first quarter fiscal 2027 earnings on September 9, 2026. Filing
  6. Jun 23, 2026ResultsReleased financial results. Filing
  7. Jun 10, 2026AnnouncementKewaunee Scientific Corporation announced that the Company plans to release results for its fourth quarter and fiscal year ended April 30, 2026 on June 23, 2026. Filing
  8. Mar 11, 2026ResultsReleased financial results. Filing
  9. Feb 25, 2026AnnouncementKewaunee Scientific Corporation announced that the Company plans to release its third quarter fiscal 2026 earnings on March 11, 2026. Filing
  10. Dec 10, 2025ResultsReleased financial results. Filing
  11. Dec 4, 2025AgreementKewaunee Scientific Corporation entered into a First Amendment to Loan Agreement with PNC Bank, National Association. Filing
  12. Nov 26, 2025AnnouncementKewaunee Scientific Corporation announced that the Company plans to release its second quarter fiscal 2026 earnings on December 10, 2025. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Kewaunee Scientific financials

Famous investors that hold KEQU

1 of the 50 well-known investors we track reported holding KEQU in their latest 13F filing. The largest position is Jim Simons's, worth $3.1M.

FundQuarterSharesValueOf portfolioChange
Jim Simons · Renaissance TechnologiesQ3 202690,911$3.1M0.0%-5%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Kewaunee Scientific Corp /De/ (KEQU) stock

Who owns the most KEQU stock?

The largest reported owner of Kewaunee Scientific Corp /De/ (KEQU) is Northern Trust Corp, with 8.3% of the company. In total, 32 funds and institutions reported holding KEQU at the end of Q2 2026, together about 42% of the shares. See the largest owners.

Are KEQU insiders buying or selling?

In the last 12 months, KEQU insiders reported no open-market purchases and 7 sales worth $293K. The latest trade was on Jan 7, 2026. See every trade.

What is the short interest in KEQU?

As of Oct 30, 2026, 38,286 KEQU shares were sold short, 1.3% of the shares outstanding, down 3.4% from the report before. At the average daily volume of 2,667 shares, buying them all back would take about 14.4 trading days (days to cover). See the history.

Which famous investors hold KEQU?

1 of the 50 well-known investors we track reported KEQU in their latest 13F filing, including Jim Simons. The largest position is worth $3.1M. See all holders.

Executive pay

Kewaunee Scientific's chief executive was paid a total of $2M for the year ended Apr 30, 2026, up 9% from $1.8M the year before. In the last 12 months, Kewaunee Scientific's executives and directors bought no stock on the open market and sold $293K.

Chief executive, total pay$2MYear ended Apr 30, 2026. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$2.8MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$795KThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.